儿童急性淋巴细胞白血病短期应用6-巯基嘌呤与肝窦阻塞综合征
在AIEOP-BFM ALL 2000试验的3983例儿童ALL患者中,分析短期6-TG应用与肝窦阻塞综合征(SOS)的关系及TPMT基因型的作用。发现17例(0.43%)发生SOS,其中13例有短期6-TG暴露(P<0.0001);低活性TPMT杂合子患者SOS风险显著增加(22.4倍,95%CI 7.1-70.7,P≤0.0001)。所有SOS患者均恢复且无残留症状。
要点
- 短期6-TG暴露与儿童ALL治疗中肝SOS发生相关。
- 低活性TPMT基因型杂合子患者SOS风险显著增高。
- 发生后SOS患者均完全恢复,无残留症状。
核心结论
- 儿童ALL治疗中短期6-TG暴露与肝SOS相关,且低活性TPMT基因型患者风险增加。
研究设计与样本
- 基于AIEOP-BFM ALL 2000试验的3983例儿童ALL患者(衍生队列),分析短期6-TG应用与肝SOS(严重不良事件)的关联及TPMT基因型作用,并有独立复制分析支持。
主要发现
- 共17例(0.43%)患者发生肝SOS,其中13例有短期6-TG暴露(P<0.0001)。
- 13例中8例为低活性TPMT变异杂合子,杂合子相比TPMT野生型患者肝SOS风险增加22.4倍(95%CI 7.1-70.7;P≤0.0001)。
- 短期6-TG后发生肝SOS的患者均恢复,无残留症状。
临床怎么用
- 儿童ALL短期应用6-TG时需警惕肝SOS风险,尤其低活性TPMT基因型患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Long-term treatment with 6-thioguanine (6-TG) for pediatric acute lymphoblastic leukemia (ALL) is associated with high rates of hepatic sinusoidal obstruction syndrome (SOS). Nevertheless, current treatment continues to use short-term applications of 6-TG with only sparse information on toxicity. 6-TG is metabolized by thiopurine methyltransferase (TPMT) which underlies clinically relevant genetic polymorphism. We analyzed the association between hepatic SOS reported as a serious adverse event (SAE) and short-term 6-TG application in 3983 pediatric ALL patients treated on trial AIEOP-BFM ALL 2000 (derivation cohort) and defined the role of TPMT genotype in this relationship. We identified 17 patients (0.43%) with hepatic SOS, 13 of which with short-term exposure to 6-TG (P < 0.0001). Eight of the 13 patients were heterozygous for low-activity TPMT variants, resulting in a 22.4-fold (95% confidence interval 7.1-70.7; P ≤ 0.0001) increased risk of hepatic SOS for heterozygotes in comparison to TPMT wild-type patients. Results were supported by independent replication analysis. All patients with hepatic SOS after short-term 6-TG recovered and did not demonstrate residual symptoms. Thus, hepatic SOS is associated with short-term exposure to 6-TG during treatment of pediatric ALL and SOS risk is increased for patients with low-activity TPMT genotypes.
引用
- Stanulla M, Schaeffeler E, Möricke A, et al. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia. Leukemia. 2021. PMID: 33714975. doi:10.1038/s41375-021-01203-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。